Keyphrases
Tirofiban
100%
Procoagulant Activity
100%
Shear-induced Platelet Activation
100%
Microparticles
66%
Abciximab
66%
P-selectin
50%
Eptifibatide
50%
Platelets
33%
Shear-induced
33%
Platelet-rich Plasma
33%
GPIIbIIIa
33%
Surface Translocation
33%
Mechanism of Action
16%
Kaolin
16%
Platelet Aggregation
16%
Inhibiting Effect
16%
Viscometer
16%
Shear Rate
16%
Thrombotic Events
16%
Platelet Glycoproteins
16%
Procoagulant Phospholipids
16%
Patients with Coronary Artery Disease
16%
Glycoprotein IIb/IIIa Receptor
16%
Clotting Time
16%
Cone-and-plate
16%
Recalcification
16%
Medicine and Dentistry
Thrombocyte Activation
100%
Procoagulant
100%
Tirofiban
100%
Abciximab
66%
Microparticle
66%
Eptifibatide
50%
PADGEM Protein
50%
Thrombocyte Rich Plasma
33%
Receptor
16%
Coronary Artery Disease
16%
Thrombocyte Aggregation
16%
Platelet
16%
Phospholipid
16%
Volunteer
16%
Thrombocyte Membrane
16%
Platelet Glycoprotein IIb/IIIa
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tirofiban
100%
Procoagulant
100%
Microparticle
66%
Abciximab
66%
Eptifibatide
50%
P-Selectin
50%
Phospholipid
16%
Receptor
16%
Coronary Artery Disease
16%
Fibrinogen Receptor
16%
Clotting Time
16%
Biochemistry, Genetics and Molecular Biology
Thrombocyte Activation
100%
Tirofiban
100%
Abciximab
66%
Eptifibatide
50%
P-Selectin
50%
Platelet-Rich Plasma
33%
Platelet
16%
Shear Rate
16%
Phospholipid
16%
Thrombocyte Membrane
16%
Platelet Glycoprotein IIb/IIIa
16%
Thrombocyte Aggregation
16%